Susquehanna International Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-348,400
Closed -$13.7M 13483
2023
Q2
$13.7M Sell
348,400
-39,400
-10% -$1.39M ﹤0.01% 2119
2023
Q1
$9.44M Buy
387,800
+42,300
+12% +$926K ﹤0.01% 2536
2022
Q4
$7.4M Sell
345,500
-272,900
-44% -$5.82M ﹤0.01% 2683
2022
Q3
$11.1M Sell
618,400
-19,100
-3% -$251K ﹤0.01% 2029
2022
Q2
$6.13M Buy
637,500
+175,000
+38% +$2.2M ﹤0.01% 2861
2022
Q1
$7.78M Buy
462,500
+160,300
+53% +$2.37M ﹤0.01% 2901
2021
Q4
$5.05M Sell
302,200
-365,600
-55% -$5.99M ﹤0.01% 3718
2021
Q3
$10.8M Buy
667,800
+519,200
+349% +$5.65M ﹤0.01% 2744
2021
Q2
$938K Sell
148,600
-339,000
-70% -$2.19M ﹤0.01% 7947
2021
Q1
$3.01M Buy
487,600
+35,200
+8% +$214K ﹤0.01% 4944
2020
Q4
$3.13M Buy
452,400
+36,600
+9% +$234K ﹤0.01% 4236
2020
Q3
$2.35M Buy
415,800
+314,400
+310% +$1.5M ﹤0.01% 4312
2020
Q2
$517K Buy
101,400
+33,300
+49% +$139K ﹤0.01% 7295
2020
Q1
$234K Sell
68,100
-135,900
-67% -$794K ﹤0.01% 8418
2019
Q4
$1.75M Buy
+204,000
New +$729K ﹤0.01% 4544
2019
Q1
Sell
-13,600
Closed -$16K 10120
2018
Q4
$16K Sell
13,600
-14,700
-52% -$28.5K ﹤0.01% 8710
2018
Q3
$67K Buy
28,300
+7,200
+34% +$17.9K ﹤0.01% 8755
2018
Q2
$58K Buy
21,100
+8,500
+67% +$23.4K ﹤0.01% 9233
2018
Q1
$35K Sell
12,600
-3,000
-19% -$8.7K ﹤0.01% 9050
2017
Q4
$49K Sell
15,600
-5,100
-25% -$14.3K ﹤0.01% 8912
2017
Q3
$58K Sell
20,700
-62,500
-75% -$169K ﹤0.01% 8508
2017
Q2
$213K Buy
83,200
+22,200
+36% +$60.5K ﹤0.01% 8188
2017
Q1
$223K Sell
61,000
-211,100
-78% -$892K ﹤0.01% 7859
2016
Q4
$1.31M Buy
272,100
+100,300
+58% +$2.98M ﹤0.01% 4948
2016
Q3
$7.92M Buy
171,800
+113,400
+194% +$6.4M ﹤0.01% 1735
2016
Q2
$2.98M Sell
58,400
-42,300
-42% -$2.1M ﹤0.01% 2940
2016
Q1
$4.26M Buy
100,700
+31,300
+45% +$1.59M ﹤0.01% 2511
2015
Q4
$5.45M Buy
69,400
+51,800
+294% +$3M ﹤0.01% 2425
2015
Q3
$713K Sell
17,600
-18,700
-52% -$991K ﹤0.01% 6428
2015
Q2
$1.89M Buy
36,300
+6,000
+20% +$298K ﹤0.01% 4835
2015
Q1
$1.41M Buy
30,300
+2,700
+10% +$140K ﹤0.01% 5058
2014
Q4
$1.24M Sell
27,600
-9,500
-26% -$399K ﹤0.01% 5434
2014
Q3
$1.44M Sell
37,100
-3,800
-9% -$149K ﹤0.01% 5205
2014
Q2
$1.73M Buy
40,900
+29,200
+250% +$1.07M ﹤0.01% 4938
2014
Q1
$418K Buy
11,700
+1,700
+17% +$57.3K ﹤0.01% 7034
2013
Q4
$324K Buy
+10,000
New +$297K ﹤0.01% 7464

Susquehanna International Group's ISEE Position: Q3 2023 in Review

Susquehanna International Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 94,992 shares — an estimated $3.74M sold.

Susquehanna International Group first reported a position in ISEE in Q4 2013 and held it in 35 quarters. The position peaked at $9.19M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Susquehanna International Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 94,992 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.74M.
  • Susquehanna International Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 35 quarters.
  • Susquehanna International Group's IVERIC bio, Inc. Common Stock position peaked at $9.19M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.